The TSLP inhibitors market is witnessing steady growth, driven by the increasing prevalence of asthma, atopic dermatitis, and other allergic inflammatory diseases. Rising adoption of targeted biologics, combined with growing awareness of TSLP’s role in Th2-driven inflammation, is…
